NO20031673L - Behandling av kreft - Google Patents
Behandling av kreftInfo
- Publication number
- NO20031673L NO20031673L NO20031673A NO20031673A NO20031673L NO 20031673 L NO20031673 L NO 20031673L NO 20031673 A NO20031673 A NO 20031673A NO 20031673 A NO20031673 A NO 20031673A NO 20031673 L NO20031673 L NO 20031673L
- Authority
- NO
- Norway
- Prior art keywords
- cancer
- treatment
- aplidine
- carnitine
- useful
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title 1
- 201000011510 cancer Diseases 0.000 title 1
- UUSZLLQJYRSZIS-LXNNNBEUSA-N plitidepsin Chemical compound CN([C@H](CC(C)C)C(=O)N[C@@H]1C(=O)N[C@@H]([C@H](CC(=O)O[C@H](C(=O)[C@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N2CCC[C@H]2C(=O)N(C)[C@@H](CC=2C=CC(OC)=CC=2)C(=O)O[C@@H]1C)C(C)C)O)[C@@H](C)CC)C(=O)[C@@H]1CCCN1C(=O)C(C)=O UUSZLLQJYRSZIS-LXNNNBEUSA-N 0.000 abstract 2
- PHIQHXFUZVPYII-ZCFIWIBFSA-O (R)-carnitinium Chemical compound C[N+](C)(C)C[C@H](O)CC(O)=O PHIQHXFUZVPYII-ZCFIWIBFSA-O 0.000 abstract 1
- 229960004203 carnitine Drugs 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 210000003205 muscle Anatomy 0.000 abstract 1
- 229950008499 plitidepsin Drugs 0.000 abstract 1
- 108010049948 plitidepsin Proteins 0.000 abstract 1
- 230000001012 protector Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/15—Depsipeptides; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0025044A GB0025044D0 (en) | 2000-10-12 | 2000-10-12 | Toxicity protection |
| GB0025209A GB0025209D0 (en) | 2000-10-13 | 2000-10-13 | Treatment of cancers |
| PCT/GB2000/004349 WO2001035974A2 (en) | 1999-11-15 | 2000-11-15 | Aplidine treatment of cancers |
| GB0107373A GB0107373D0 (en) | 2001-03-23 | 2001-03-23 | Aplidine |
| PCT/GB2001/004555 WO2002030441A2 (en) | 2000-10-12 | 2001-10-12 | Treatment of cancers by aplidine in conjunction with a myoprotector |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20031673D0 NO20031673D0 (no) | 2003-04-11 |
| NO20031673L true NO20031673L (no) | 2003-06-12 |
Family
ID=27255931
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20031673A NO20031673L (no) | 2000-10-12 | 2003-04-11 | Behandling av kreft |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US7507766B2 (de) |
| JP (1) | JP2010031043A (de) |
| KR (1) | KR20030038812A (de) |
| CN (1) | CN1479622A (de) |
| AT (1) | ATE299028T1 (de) |
| BR (1) | BR0114604A (de) |
| CZ (1) | CZ2003993A3 (de) |
| ES (1) | ES2243555T3 (de) |
| HK (1) | HK1054191A1 (de) |
| IL (1) | IL155273A0 (de) |
| NO (1) | NO20031673L (de) |
| NZ (1) | NZ525196A (de) |
| PL (1) | PL361179A1 (de) |
| RU (1) | RU2003113210A (de) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HK1045648B (en) * | 1999-11-15 | 2007-09-21 | Pharma Mar, S.A. | Aplidine treatment of cancers |
| WO2004080421A2 (en) * | 2003-03-12 | 2004-09-23 | Pharma Mar, S.A. | Improved antitumoral treatments |
| WO2007100385A2 (en) * | 2005-10-31 | 2007-09-07 | Genentech, Inc. | Macrocyclic depsipeptide antibody-drug conjugates and methods |
| WO2007101235A2 (en) * | 2006-02-28 | 2007-09-07 | Pharma Mar, S.A. | Improved antitumoral treatments |
| JP2011500650A (ja) * | 2007-10-19 | 2011-01-06 | ファルマ・マール・ソシエダード・アノニマ | 改良された抗腫瘍治療 |
| AU2009221720A1 (en) * | 2008-03-07 | 2009-09-11 | Pharma Mar, S.A. | Improved anticancer treatments |
| EP2717884A1 (de) | 2011-06-06 | 2014-04-16 | Chevron Phillips Chemical Company LP | Verwendung von metallocenverbindungen zur krebsbehandlung |
| JOP20190254A1 (ar) | 2017-04-27 | 2019-10-27 | Pharma Mar Sa | مركبات مضادة للأورام |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4493796A (en) | 1980-09-12 | 1985-01-15 | Board Of Trustees, Univ. Of Ill. | Didemnins A, B, C, and derivatives thereof, as antiviral agents |
| EP0048149B1 (de) | 1980-09-12 | 1983-11-30 | University of Illinois Foundation | Antibiotika, Derivate davon, Verfahren zu deren Extraktion und jene enthaltende Ansätze |
| US4950649A (en) | 1980-09-12 | 1990-08-21 | University Of Illinois | Didemnins and nordidemnins |
| IT1153974B (it) | 1982-09-23 | 1987-01-21 | Erba Farmitalia | Composizioni farmacologiche a base di cisplatino e metodo per il loro ottenimento |
| US4948791A (en) | 1989-04-10 | 1990-08-14 | The Board Of Trustees Of The University Of Illinois | Novel Cytotoxic cyclic depsipeptides from the tunicate trididemnum solidum |
| GB8922026D0 (en) | 1989-09-29 | 1989-11-15 | Pharma Mar Sa | Novel anti-viral and cytotoxic agent |
| DE4120327A1 (de) | 1991-06-20 | 1992-12-24 | Basf Ag | Neue peptide, ihre herstellung und verwendung |
| US5462726A (en) | 1993-12-17 | 1995-10-31 | Bristol-Myers Squibb Company | Method of inhibiting side effects of solvents containing ricinoleic acid or castor oil or derivatives thereof employing a thromboxane A2 receptor antagonist and pharmaceutical compositions containing such solvents |
| US5861439A (en) | 1994-11-14 | 1999-01-19 | Alza Corporation | Method for enhanced electrotransport agent delivery |
| ES2102322B1 (es) | 1995-07-13 | 1998-03-01 | Pharma Mar Sa | Procedimiento de preparacion de didemnina a. |
| DE69703294T2 (de) | 1996-05-22 | 2001-05-17 | Protarga Inc., Conshohocken | Zusammensetzungen die konjugate von cis-docosahexaenoic-säure und taxotere enthalten |
| US6156724A (en) | 1996-06-07 | 2000-12-05 | Rinehart; Kenneth L. | Uses of didemnins as immunomodulating agents |
| ATE208324T1 (de) | 1996-07-03 | 2001-11-15 | Paxton C G Ltd | Behälter |
| DK0956033T3 (da) | 1996-10-24 | 2003-10-06 | Univ Illinois | Totalsyntese af amino-Hip-analogen af didemnin A |
| ES2262175T3 (es) | 1996-10-24 | 2006-11-16 | The Board Of Trustees Of The University Of Illinois | Estudios semisinteticos para dar analogos de didemnina. |
| US6034058A (en) | 1997-04-15 | 2000-03-07 | Rinehart; Kenneth L. | Semi-synthetic alanyl dilemnin analogs |
| WO1998050048A1 (en) | 1997-05-07 | 1998-11-12 | Pharma Mar, S.A. | Aplidine as an l-type calcium channel enhancer |
| GB9803448D0 (en) | 1998-02-18 | 1998-04-15 | Pharma Mar Sa | Pharmaceutical formulation |
| CA2338638C (en) * | 1998-07-30 | 2009-03-17 | Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. | Use of l-carnitine and its alkanoyl derivatives in the preparation of medicaments with anticancer activity |
| US20010021380A1 (en) | 1999-04-19 | 2001-09-13 | Pluenneke John D. | Soluble tumor necrosis factor receptor treatment of medical disorders |
| US6890904B1 (en) | 1999-05-25 | 2005-05-10 | Point Therapeutics, Inc. | Anti-tumor agents |
| JP2003500360A (ja) | 1999-05-25 | 2003-01-07 | ポイント セラピューティクス， インコーポレイテッド | ボロプロリン化合物類を含む抗癌剤 |
| HK1045648B (en) | 1999-11-15 | 2007-09-21 | Pharma Mar, S.A. | Aplidine treatment of cancers |
| DE60123232T2 (de) | 2000-04-07 | 2007-11-08 | Trustees Of The University Of Pennsylvania | Tamandarin und didemnin analoga und methoden zu deren herstellung und verwendung |
| US6509315B1 (en) | 2000-04-07 | 2003-01-21 | The Trustees Of The University Of Pennsylvania | Didemnin analogs and fragments and methods of making and using them |
| UA76718C2 (uk) | 2000-06-30 | 2006-09-15 | Фарма Мар, С.А. | Протипухлинні похідні аплідину |
| WO2002028902A2 (en) | 2000-10-05 | 2002-04-11 | Immunex Corporation | Nectin polypeptides, polynucleotides, methods of making and use thereof |
| DE60111858T2 (de) | 2000-10-12 | 2006-04-20 | Pharma Mar, S.A., Tres Cantos | BEHANDLUNG VON KREBSERKRANKUNGEN mit APLIDIN IN KOMBINATION MIT CARNITIN ODER ACETYLCARNITIN |
| WO2002032374A2 (en) | 2000-10-18 | 2002-04-25 | Immunex Corporation | Methods for treating il-18 mediated disorders |
| PT1435991E (pt) | 2001-10-19 | 2009-01-16 | Pharma Mar Sa | Utilização de aplidina para o tratamento de cancro pancreático |
| WO2004080421A2 (en) | 2003-03-12 | 2004-09-23 | Pharma Mar, S.A. | Improved antitumoral treatments |
-
2001
- 2001-10-12 ES ES01974510T patent/ES2243555T3/es not_active Expired - Lifetime
- 2001-10-12 NZ NZ525196A patent/NZ525196A/en unknown
- 2001-10-12 KR KR10-2003-7005081A patent/KR20030038812A/ko not_active Withdrawn
- 2001-10-12 RU RU2003113210/14A patent/RU2003113210A/ru not_active Application Discontinuation
- 2001-10-12 CN CNA018204740A patent/CN1479622A/zh active Pending
- 2001-10-12 PL PL01361179A patent/PL361179A1/xx not_active Application Discontinuation
- 2001-10-12 BR BR0114604-1A patent/BR0114604A/pt not_active IP Right Cessation
- 2001-10-12 HK HK03106440.0A patent/HK1054191A1/zh unknown
- 2001-10-12 IL IL15527301A patent/IL155273A0/xx unknown
- 2001-10-12 AT AT01974510T patent/ATE299028T1/de not_active IP Right Cessation
- 2001-10-12 CZ CZ2003993A patent/CZ2003993A3/cs unknown
- 2001-10-12 US US10/398,835 patent/US7507766B2/en not_active Expired - Fee Related
-
2003
- 2003-04-11 NO NO20031673A patent/NO20031673L/no not_active Application Discontinuation
-
2009
- 2009-11-06 JP JP2009255266A patent/JP2010031043A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| KR20030038812A (ko) | 2003-05-16 |
| NZ525196A (en) | 2004-09-24 |
| RU2003113210A (ru) | 2004-11-27 |
| IL155273A0 (en) | 2003-11-23 |
| ES2243555T3 (es) | 2005-12-01 |
| BR0114604A (pt) | 2003-10-14 |
| JP2010031043A (ja) | 2010-02-12 |
| CZ2003993A3 (cs) | 2004-02-18 |
| ATE299028T1 (de) | 2005-07-15 |
| US7507766B2 (en) | 2009-03-24 |
| US20040010043A1 (en) | 2004-01-15 |
| NO20031673D0 (no) | 2003-04-11 |
| HK1054191A1 (zh) | 2003-11-21 |
| CN1479622A (zh) | 2004-03-03 |
| PL361179A1 (en) | 2004-09-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20024610D0 (no) | Synergistiske metoder og blandinger for behandling av kreft | |
| HN2001000244A (es) | Inhibidores de espiropirimidin - 2, 4, 6 - triona metaloproteinasas. | |
| EA200501251A1 (ru) | Антинеопластические комбинации | |
| EP1478406A4 (de) | Zusammensetzungen zur abgabe von therapeutika und anderen materialien und verfahren zu ihrer herstellung und verwendung | |
| HN2001000243A (es) | Inhibidores de metaloproteinasa del tipo pirimidin - 2, 4, 6 - triona | |
| CY1108610T1 (el) | Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες | |
| EP1240280A4 (de) | Behandlung von kohle | |
| PT1235571E (pt) | Utilizacao de melatonina para o tratamento da alopecia androgenetica e difusa do tipo feminino | |
| IS6575A (is) | Hýdroxýfenýl-píperidín-4-ýlíden-metýl-bensamíðafleiður til að meðhöndla sársauka | |
| TR200103819T2 (tr) | kanser tedavisinde ET743 terkipleri ve kullanımları | |
| NO994274D0 (no) | Sammensetninger til Õ behandle tumörer inneholdende haibruskekstrakter og antineoplastiske forbindelser | |
| IL153680A0 (en) | Aplidine derivatives and methods for the preparation thereof | |
| DK1237549T3 (da) | Lipoxin A4 og dets analoger til behandling af törre öjne | |
| EA200200922A1 (ru) | Композиция, включающая камптотецин и производное пиримидина, для лечения рака | |
| SE9802208D0 (sv) | Novel compounds | |
| NO20031860L (no) | Kahalalid F | |
| NO20031673L (no) | Behandling av kreft | |
| ATE516027T1 (de) | Orazamid orotat zur vorbeugung von leberschäden | |
| FI20000635A0 (fi) | COMT-inhibiittoreiden käyttö analgeettina | |
| ATE275143T1 (de) | Verbindungen | |
| IS6574A (is) | Kínólinýl-píperidín-4-ýlíden-metýl-bensamíðafleiður til að meðhöndla sársauka | |
| IS6563A (is) | Hýdroxýfenýl-píperasinýl-metýl-bensamíðafleiður til að meðhöndla sársauka | |
| EE200300129A (et) | Distamütsiini alfa-halogenoakrüloüülderivaadi kasutamine | |
| DE60110748D1 (de) | Behandlung von fluorkohlenstoff-beschickungen | |
| UY26085A1 (es) | N-[-(4-aminofenil)-2,3-dihidro-1,4-benzodioxina-2-metanamina su preparacion y su aplicacion en terapeutica |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |